Details for Patent: 5,691,374
✉ Email this page to a colleague
Summary for Patent: 5,691,374
| Title: | Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors |
| Abstract: | The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I. |
| Inventor(s): | Black; Cameron (Point Claire, CA), Grimm; Erich (Baie D'Urfe, CA), Wang; Zhaoyin (Pierrefonds, CA), Leger; Serge (Dollard des Ormeaux, CA) |
| Assignee: | Merck Frosst Canada Inc. (Kirkland, CA) |
| Application Number: | 08/443,620 |
|
Patent Claim Types: see list of patent claims | Compound; Use; Composition; |
Drugs Protected by US Patent 5,691,374
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,691,374
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 210124 | ⤷ Sign Up | |||
| Australia | 5642496 | ⤷ Sign Up | |||
| Australia | 707773 | ⤷ Sign Up | |||
| Canada | 2219129 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
